Sherry Pierce

Sherry Pierce

UNVERIFIED PROFILE

Are you Sherry Pierce?   Register this Author

Register author
Sherry Pierce

Sherry Pierce

Publications by authors named "Sherry Pierce"

Are you Sherry Pierce?   Register this Author

100Publications

3713Reads

19Profile Views

Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis.

Ann Hematol 2019 Jul 15;98(7):1611-1616. Epub 2019 May 15.

Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1468, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03708-9DOI Listing
July 2019

High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma.

Mod Pathol 2019 01 4;32(1):48-58. Epub 2018 Sep 4.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41379-018-0112-9
Publisher Site
http://dx.doi.org/10.1038/s41379-018-0112-9DOI Listing
January 2019

Prognostic significance of hyperdiploidy in adult acute myeloid leukemia.

Am J Hematol 2018 11 9;93(11):E357-E360. Epub 2018 Sep 9.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25240DOI Listing
November 2018

Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition.

Cancer Res 2018 05 28;78(10):2721-2731. Epub 2018 Feb 28.

Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-0949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955838PMC
May 2018

Time to response and survival in hypomethylating agent-treated acute myeloid leukemia.

Leuk Lymphoma 2018 04 25;59(4):1012-1015. Epub 2017 Aug 25.

a Department of Leukemia , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1365857DOI Listing
April 2018

Outcomes of Patients With Relapsed Core Binding Factor-Positive Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2018 01 25;18(1):e19-e25. Epub 2017 Sep 25.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.09.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861376PMC
January 2018

Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.

Ann Hematol 2018 Jan 15;97(1):109-121. Epub 2017 Nov 15.

Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, 1400 Holcombe Blvd, Unit 428, PO Box 301439, Houston, TX, 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3165-9DOI Listing
January 2018

THE RELATIONSHIP BETWEEN SEGMENTAL ROLLING ABILITY AND LUMBAR MULTIFIDUS ACTIVATION TIME.

Int J Sports Phys Ther 2017 Nov;12(6):921-930

Belmont University, School of Physical Therapy, Nashville, TN USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675368PMC
November 2017

Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions.

Ann Hematol 2017 May 28;96(5):733-738. Epub 2017 Feb 28.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-2956-3DOI Listing
May 2017

Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics.

Leuk Lymphoma 2016 May 19;57(5):1054-9. Epub 2015 Oct 19.

a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1092527DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837105PMC
May 2016

Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML).

Clin Lymphoma Myeloma Leuk 2016 Apr 5;16(4):213-222.e2. Epub 2016 Jan 5.

Department of Leukemia, and Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811701PMC
April 2016

Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.

J Natl Cancer Inst 2015 Nov 13;108(2). Epub 2015 Nov 13.

Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA (JY, JJ, NJMR, MC, JPJI); Department of Leukemia (JY, RT, JJ, NJMR, SAP, SMK, FR, HMK, JPJI) and Department of Hematopathology (CEBR), The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862435PMC
November 2015

Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia.

J Infect Chemother 2015 Sep 9;21(9):663-7. Epub 2015 Jun 9.

Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jiac.2015.05.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459324PMC
September 2015

Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities.

Leuk Res 2015 Apr 2;39(4):419-23. Epub 2015 Feb 2.

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2015.01.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847531PMC
April 2015